欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2426/001
药品名称Bortezomib Mylan
活性成分
    • BORTEZOMIB 3.5 mg
剂型Powder for solution for injection
上市许可持有人Mylan Hospital AS Sørkedalsveien 10B 0369 Oslo Norway
参考成员国 - 产品名称Denmark (DK)
Bortezomib Mylan
互认成员国 - 产品名称
    • Luxembourg (LU)
    • United Kingdom (GB)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Hungary (HU)
    • Slovakia (SK)
许可日期2015/11/10
最近更新日期2019/01/11
药物ATC编码
    • L01XX32 bortezomib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Withdrawn(注:已撤市)
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase